Vir Biotechnology
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $240 | $1,214 | $3,032 | $12,374 |
Gross Profit | -151,212 | -96,306 | -114,583 | -76,415 |
EBITDA | -159,975 | -115,672 | -135,660 | -100,230 |
EBIT | -162,973 | -118,589 | -138,527 | -103,116 |
Net Income | -163,141 | -110,958 | -120,965 | -104,589 |
Net Change In Cash | 240 | 1,214 | 3,032 | 12,374 |
Free Cash Flow | -167,887 | -122,757 | -79,745 | -90,042 |
Cash | 170,084 | 211,104 | 273,571 | 222,947 |
Basic Shares | 138,930 | 138,447 | 137,469 | 136,809 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $74,205 | $86,180 | $1,615,797 | $1,095,415 |
Gross Profit | -404,440 | -486,647 | 994,830 | 581,544 |
EBITDA | -508,912 | -641,637 | 839,851 | 426,562 |
EBIT | -523,471 | -661,088 | 833,068 | 420,751 |
Net Income | -521,960 | -615,061 | 515,837 | 528,583 |
Net Change In Cash | 74,205 | 86,180 | 1,615,797 | 1,095,415 |
Cost of Revenue | -88,072 | |||
Free Cash Flow | -453,653 | -800,358 | 1,595,247 | -69,406 |
Cash | 222,947 | 241,576 | 848,631 | 347,815 |
Basic Shares | 136,247 | 134,130 | 134,810 | 133,437 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$1.17 |
2025-06-30 | -$0.80 |
2025-03-31 | -$0.88 |
2024-12-31 | -$0.76 |
